Comparing Paroxetine and Duloxetine on Cardiovascular Measures
Completed · Phase 2/Phase 3
Conditions studied: Depressive Symptoms
In brief
This double-blind placebo-controlled trial is designed to test and to compare the cardiovascular profile of paroxetine controlled release (CR) with duloxetine in outpatients with depressive symptoms.
Key facts
- Study ID
- NCT00136383
- Run by
- Duke University
- People needed
- 40
- Starts
- 2005-03-01
- Expected to finish
- 2007-06-01
- Last updated by the study team
- 2014-07-21
Who can join
Age: 20 and older, up to 60. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Depressive symptoms
- Ages 20-60
- In good medical health and not pregnant
You may not qualify if…
- Bipolar disorder
- Schizophrenia or other psychotic disorder
- Alcohol or other substance abuse within the last 3 months
- Cognitive impairment
- History of attempted suicide in the past 2 months and who score 4 or more on the suicide item of the MADRS
Where it is running
- Duke University Medical Center — Durham, North Carolina, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.